首页> 外文期刊>International Journal of Basic & Clinical Pharmacology >The prescribing pattern for the management of dengue fever in pediatric patients of a tertiary care hospital: an observational study
【24h】

The prescribing pattern for the management of dengue fever in pediatric patients of a tertiary care hospital: an observational study

机译:三级医院儿科患者登革热治疗的处方模式:一项观察性研究

获取原文
           

摘要

Background: Dengue fever is a mosquito borne viral infection which has become a global health hazard, especially in tropical and subtropical areas. Children have higher risk of developing severe forms of dengue fever, however, studies show that paediatric complications/fatalities from dengue fever are potentially avoidable by proper management. Data about drug usage patterns for dengue are particularly lacking, especially in the paediatric age group, therefore this study will help facilitate the rational use of drugs and aid in establishing a more specific management for dengue fever. The objective of the present study was to identify the prescribing pattern of dengue fever in paediatric inpatients admitted to RajaRajeswari Medical College and Hospital and assess according to the WHO core prescribing indicators Methods: This prospective observational study took place from March 2017 to September 2017 in the paediatric general wards. Data was collected from case files of NS1 positive patients of both genders between 1-18years. Data was analysed using descriptive statistics and expressed as percentages, means and standard deviations. The prescription pattern was analysed using the prescribing indicators mentioned in the World Health Organization core drug use indicators. Results: Total of 300 drugs were prescribed for 110 prescriptions that were analysed excluding IV fluids and blood products. Mean number of drugs prescribed was 2.7±0.8. Drugs prescribed by a generic name was 7.33%. Patients prescribed an antibiotic was 12.73%. Patients prescribed with an injection was 62.72% Majority of drugs prescribed in this study come from essential medicines list created by regulatory bodies. Intravenous fluids were administered to all patients with majority receiving normal saline (60.9%). Conclusions: Mainstay of treatment of dengue fever for paediatric patients is symptomatic along with focus on fluid management. Majority of drugs prescribed are from essential medicines lists formed by regulatory bodies. With dengue infections being a worldwide health hazard, more studies are needed to facilitate rational use of drugs in this disease.
机译:背景:登革热是一种由蚊子传播的病毒感染,已经成为一种全球性健康危害,尤其是在热带和亚热带地区。儿童罹患严重形式的登革热的风险较高,但是,研究表明,通过适当的管理有可能避免小儿并发症/登革热致死。特别是在儿童年龄组中,尤其缺乏有关登革热药物使用模式的数据,因此,本研究将有助于促进药物的合理使用,并帮助建立更具体的登革热管理方法。本研究的目的是确定RajaRajeswari医学院和医院收治的儿科患者登革热的处方模式,并根据WHO的主要处方指标进行评估。方法:这项前瞻性观察性研究于2017年3月至2017年9月期间在儿科普通病房。数据收集自1-18岁之间的两个性别均为NS1阳性的患者。使用描述性统计数据分析数据,并表示为百分比,均值和标准差。使用世界卫生组织核心药物使用指标中提到的处方指标对处方模式进行了分析。结果:分析了110种处方,总共开出300种药物,其中不包括静脉输液和血液制品。开出的平均药物数为2.7±0.8。以通用名开具的药物占7.33%。开处方抗生素的患者为12.73%。注射处方的患者占62.72%。本研究中处方的药物多数来自监管机构制定的基本药物清单。对所有多数接受生理盐水(60.9%)的患者进行静脉输液。结论:小儿登革热治疗的主要症状是对症治疗,同时侧重于输液管理。多数处方药来自监管机构制定的基本药物清单。由于登革热感染是一种全球性的健康危害,需要进行更多的研究以促进对该疾病药物的合理使用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号